Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fármaco Uruguayo is a leading pharmaceutical company based in Montevideo, Uruguay, dedicated to the development, production, and marketing of a diverse range of healthcare products. Founded in 1940, the company established itself as a key player in the local market before being acquired by the Brazilian multinational Eurofarma in 2010, marking Eurofarma's first international acquisition. The company operates a significant manufacturing plant that produces branded generics and hospital-grade medications across various therapeutic areas, including cardiology, gastroenterology, and pain management. Fármaco Uruguayo serves both the retail pharmacy sector and institutional healthcare providers, maintaining high quality standards through its GMP-certified facilities. Today, it functions as the Uruguayan hub for Eurofarma's regional operations, focusing on expanding access to affordable and effective therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fármaco Uruguayo.